Nature Medicine | Spoonful of Medicine
Broad-acting antibody brings researchers one step closer to a universal flu shot
A universal flu vaccine is high on the wishlists of most immunologists, virologists — and even funding agencies. This week US National Institutes of Health director Francis Collins told USAToday that he’s “guardedly optimistic” that such a long-term shot will be developed within the next five years. That timeline could be aided by a report out today in Science that a single antibody is capable of inactivating all subtypes of influenza A.
Recent comments
Real-time tissue analysis could guide brain tumor surgery
Bundled RNA balls silence brain cancer gene expression
Ebola outbreak in West Africa lends urgency to recently-funded research